Halozyme Therapeutics shares owned by Bridgewater Associates
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Bridgewater Associates
from 13F filings
Historical chart of Bridgewater Associates investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Bridgewater Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Bridgewater Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $33M | 511k | 64.63 |
| 2025-12-31 | $38M | 562k | 67.30 |
| 2025-09-30 | $36M | 487k | 73.34 |
| 2024-09-30 | $659k | 12k | 57.24 |
| 2024-06-30 | $1.7M | 33k | 52.36 |
| 2024-03-31 | $287k | 7.1k | 40.68 |
| 2023-12-31 | $261k | 7.1k | 36.96 |
| 2023-09-30 | $270k | 7.1k | 38.20 |
| 2023-06-30 | $2.2M | 62k | 36.07 |